1. Mor G, Cardenas I. The immune system in pregnancy: a unique complexity. Am J Reprod Immunol. 2010;63(6):425–433.
2. Robinson DP, Klein SL. Pregnancy and pregnancy-associated hormones alter immune responses and disease pathogenesis. Horm Behav. 2012;62(3):263–271.
3. Jamieson DJ, Theiler RN, Rasmussen SA. Emerging infections and pregnancy. Emerg Infect Dis. 2006;12(11):1638–1643.
4. Kourtis AP, Read JS, Jamieson DJ. Pregnancy and infection. N Engl J Med. 2014;370(23):2211–2218.
5. Hill JB, Sheffield JS, McIntire DD, et al. Acute pyelonephritis in pregnancy. Obstet Gynecol. 2005;105(1):18–23.
6. Urinary Tract Infections in Pregnant Individuals. Obstet Gynecol. 2023 Aug 1;142(2):435-445. doi: 10.1097/AOG.0000000000005269. PMID: 37473414.
7. Soma-Pillay P, Nelson-Piercy C, Tolppanen H, et al. Physiological changes in pregnancy: review articles. Cardiovasc J Afr. 2016;27(2):89–94.
8. Manns-James L. Bacterial vaginosis and preterm birth. J Midwifery Womens Health. 2011 Nov-Dec;56(6):575-83. doi: 10.1111/j.1542-2011.2011.00086.x. Epub 2011 Sep 13. PMID: 22060217.
9. White SE, Heine RP, Widelock TM. Antibiotic Considerations in the Treatment of Maternal Sepsis. Antibiotics (Basel). 2025 Apr 7;14(4):387. doi: 10.3390/antibiotics14040387. PMID:
40298544; PMCID: PMC12024307
10. Reid G, Younes JA, Van der Mei HC, et el. Microbiota restoration: natural and supplemented recovery of human microbial communities. Nat Rev Microbiol. 2011;9(1):27–38.
11. Neu N, Duchon J, Zachariah P. TORCH infections. Clin Perinatol. 2015;42(1):77–103
12. Nguyen J, Madonia V, Bland CM,et al.; as part of the Southeastern Research Group Endeavor (SERGE‐45) research network. A review of antibiotic safety in pregnancy-2025 update. Pharma-
cotherapy. 2025 Apr;45(4):227-237. doi: 10.1002/phar.70010. Epub 2025 Mar 19. PMID: 40105039; PMCID: PMC11998890.
13. Pernia S, DeMaagd G. The New Pregnancy and Lactation Labeling Rule. P T. 2016;41(11):713-715.
14. Bookstaver, P.B., Bland, C.M., Griffin, B., Stover, K.R., et al. (2015), A Review of Antibiotic Use in Pregnancy. Pharmacotherapy, 35: 1052-1062. https://doi.org/10.1002/phar.1649
15. Lee, Y., Kim, J., & Trinh, S. (2019). Meropenem-Vaborbactam (Vabomere™ ): Another Option for Carbapenem-Resistant Enterobacteriaceae. P & T : a peer-reviewed journal for formulary
management, 44(3), 110–113.
16. European AIDS Clinical Society (EACS). (2025). EACS Guidelines, version 13.0 (https://www.eacsociety.org/guidelines/eacs-guidelines/). Accessed: 31 Ekim 2025.
17. Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep. 2021 Jul 23;70(4):1-187. doi: 10.15585/mmwr.rr7004a1.
PMID: 34292926; PMCID: PMC8344968.
18. Bhimraj A, Morgan RL, Shumaker AH, et al. Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (September 2022). Clin Infect
Dis. 2024 Jun 27;78(7):e250-e349. doi: 10.1093/cid/ciac724. PMID: 36063397; PMCID: PMC9494372.
19. Joseph NT, Collier AY. COVID-19 Therapeutics and Considerations for Pregnancy. Obstet Gynecol Clin North Am. 2023 Mar;50(1):163-182. doi: 10.1016/j.ogc.2022.10.018. Epub 2022 Oct
21. PMID: 36822701; PMCID: PMC9584862.
20. Erköseoğlu İ. Antifungal İlaçların Gebelik ve Emzirmede Kullanımı. Kalyoncu Nİ, Kadıoğlu Duman M, editörler. Gebelik ve Emzirme Döneminde Klinik Farmakoloji. 1. Baskı. Ankara:
Türkiye Klinikleri; 2018. p.23-8.
21. Patel MA, Aliporewala VM, Patel DA. Common Antifungal Drugs in Pregnancy: Risks and Precautions. J Obstet Gynaecol India. 2021 Dec;71(6):577-582. doi: 10.1007/s13224-021-01586-8.
Epub 2021 Nov 9. PMID: 34898894; PMCID: PMC8617216.
22. Centers for Disease Control and Prevention (CDC). Screening and testing for HIV, viral hepatitis, STIs & TB in pregnancy [Internet]. Atlanta (GA): CDC; [updated 2025; cited 2025 Nov 1].
Available from: https://www.cdc.gov/pregnancy-hiv-std-tb-hepatitis/php/screening/index.html.
23. Kahraman Kilbas, E. P., Ciftci, I. H., Kilbas, I., & Toptan, H. (2025). Seroprevalence of TORCH Viral Agents in Pregnant Women in Turkey: Systematic Review and Meta-Analysis. Pathogens
(Basel, Switzerland), 14(1), 37. https://doi.org/10.3390/pathogens14010037.
24. Parums DV. A Review of Emerging Viral Pathogens and Current Concerns for Vertical Transmission of Infection. Med Sci Monit. 2024 Nov 23;30:e947335. doi: 10.12659/MSM.947335.
PMID: 39578400; PMCID: PMC11600638.
25. Centers for Disease Control and Prevention. Pregnancy and rubella. Updated July 11, 2025. Accessed October 30, 2025.
26. Cerisola A, Francia M, Gesuele JP. Congenital toxoplasmosis. Semin Pediatr Neurol. 2025 Jul;54:101203. doi: 10.1016/j.spen.2025.101203. Epub 2025 Jun 20. PMID: 40701684.
27. Malatyalı E, Yıldız İ, Tileklioğlu E, ve ark. Retrospective Analysis of Toxoplasma gondii Serology Results from Adnan Menderes University Faculty of Medicine Parasitology Laboratory from
2007 to 2017. Turkiye Parazitol Derg 2019; 43: 1-4
28. Rostami A, Riahi SM, Contopoulos-Ioannidis DG, et al . Acute Toxoplasma infection in pregnant women worldwide: A systematic review and meta-analysis. PLoS Negl Trop Dis. 2019 Oct
14;13(10):e0007807. doi: 10.1371/journal.pntd.0007807. PMID: 31609966; PMCID: PMC6822777.
29. Durdu, C.-E., & Bohîlțea, R.-E. (2023). Toxoplasmosis and Pregnancy: Current Approaches for Favourable Fetal Outcome. Romanian Journal of Preventive Medicine, 2(3), 12-21. https://doi.
org/10.3390/rjpm2030012
30. Lorea CF, Pressman K, Schuler-Faccini L. Infections during pregnancy: An ongoing threat. Semin Perinatol. 2025 Jun;49(4):152075. doi: 10.1016/j.semperi.2025.152075. Epub 2025 Apr
PMID: 40189453.
31. Pontes, K. F. M., & Araujo Júnior, E. (2024). Cytomegalovirus and pregnancy: current evidence for clinical practice. Revista da Associacao Medica Brasileira (1992), 70(8), e20240509. https://
doi.org/10.1590/1806-9282.20240509
32. Sorrenti, S., Elbarbary, N., D’Antonio, F.,et al. (2025). Diagnosis and management of congenital cytomegalovirus: Critical appraisal of clinical practice guidelines. European Journal of Obstetrics
& Gynecology and Reproductive Biology, 306, 172–180. https://doi.org/10.1016/j.ejogrb.2025.01.020.
33. Society for Maternal-Fetal Medicine. (2024, August 27). SMFM update on human parvovirus B19 in pregnancy. https://www.smfm.org/parvovirus-b19. Retrieved October 30, 2025.
34. Dittmer, F.P.; Guimarães, C.d.M.; Peixoto, A.B.; et al. Parvovirus B19 Infection and Pregnancy: Review of the Current Knowledge. J. Pers. Med. 2024, 14, 139. https://doi.org/ 10.3390/
jpm14020139
35. Ion, A., Orzan, O. A., & Bălăceanu-Gurău, B. (2025). Varicella Zoster Virus Infection and Pregnancy: An Optimal Management Approach. Pathogens (Basel, Switzerland), 14(2), 151.
https://doi.org/10.3390/pathogens14020151
36. De Rose DU, Bompard S, Maddaloni C, et al. Neonatal herpes simplex virus infection: From the maternal infection to the child outcome. J Med Virol. 2023 Aug;95(8):e29024. doi: 10.1002/
jmv.29024. PMID: 37592873.
37. Ali H, Kumar S, Kratzer MK, Kinderwater J. Disseminated herpes simplex infection induced hepatitis during pregnancy mimicking HELLP syndrome, a diagnostic challenge. Infect Med
(Beijing). 2022 Jan 6;1(1):67-72. doi: 10.1016/j.imj.2021.12.001. PMID: 38074975; PMCID: PMC10699672.
38. Workowski, K. A., Bachmann, L. H., Chan, P. A.,et al. (2021). Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR. Recommendations and reports : Morbidity and mortality
weekly report. Recommendations and reports, 70(4), 1–187. https://doi.org/10.15585/mmwr.rr7004a1
39. d’Hemecourt K, Santos E, Guerina N, et al. Syphilis in Pregnancy and Congenital Syphilis. R I Med J (2013). 2024 Dec 2;107(12):16-19. PMID: 39576996.
40. Desjardins AA, Amaral E, Miranda J, et al. Syphilis in pregnancy: A practical guide for prenatal care providers. Int J Gynecol Obstet. 2025; 171: 601-610. doi:10.1002/ijgo.70511
41. Ke, Y., Ye, L., Zhu, P. et al. Listeriosis during pregnancy: a retrospective cohort study.BMC Pregnancy Childbirth 22, 261 (2022). https://doi.org/10.1186/s12884-022-04613-2
42. Grant A, Bai K, Badalato GM, Rutman MP. Advances in the Treatment of Urinary Tract Infection and Bacteriuria in Pregnancy. Urol Clin North Am. 2024 Nov;51(4):571-583. doi: 10.1016/j.
ucl.2024.07.001. Epub 2024 Aug 17. PMID: 39349024.
43. Miele K, Bamrah Morris S, Tepper NK. Tuberculosis in Pregnancy. Obstet Gynecol. 2020 Jun;135(6):1444-1453. doi: 10.1097/AOG.0000000000003890. PMID: 32459437; PMCID:
PMC7975823.
44. Nahid P, Dorman SE, Alipanah N, et al. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines:
Treatment of Drug-Susceptible Tuberculosis. Clin Infect Dis. 2016 Oct 1;63(7):e147-e195. doi: 10.1093/cid/ciw376. Epub 2016 Aug 10. PMID: 27516382; PMCID: PMC6590850.
45. Tüberküloz Tanı ve Tedavi Rehberi, 2. Baskı Ankara, Mayıs 2019
46. Chen, Y. H., Keller, J., Wang, I. T., et al. (2012). Pneumonia and pregnancy outcomes: a nationwide population-based study. American journal of obstetrics and gynecology, 207(4), 288.e1–288.
e2887. https://doi.org/10.1016/j.ajog.2012.08.023
47. Tang, P., Wang, J. & Song, Y. Characteristics and pregnancy outcomes of patients with severe pneumonia complicating pregnancy: a retrospective study of 12 cases and a literature review. BMC
Pregnancy Childbirth 18, 434 (2018). https://doi.org/10.1186/s12884-018-2070-0
48. Influenza in Pregnancy: Prevention and Treatment: ACOG Committee Statement No. 7. Obstet Gynecol. 2024 Feb 1;143(2):e24-e30. doi: 10.1097/AOG.0000000000005479. PMID: 38016152.
49. Centers for Disease Control and Prevention. (2024, September 17). Influenza and pregnancy. https://www.cdc.gov/flu/highrisk/pregnant.htm
50. Adeyanju GC, Engel E, Koch L, Ranzinger T, Shahid IBM, Head MG, Eitze S, Betsch C. Determinants of influenza vaccine hesitancy among pregnant women in Europe: a systematic review.
Eur J Med Res. 2021 Sep 28;26(1):116. doi: 10.1186/s40001-021-00584-w. PMID: 34583779; PMCID: PMC8477621.
51. Idowu MB, Dotters-Katz SK, Kuller JA, Grace MR, Gatta LA. Seasonal Influenza in Pregnancy. Obstet Gynecol Surv. 2025 Jul;80(7):432-442. doi: 10.1097/OGX.0000000000001406. PMID:
40598809.
52. Centers for Disease Control and Prevention. (2025, June 11). Clinical considerations for special populations. https://www.cdc.gov/covid/hcp/clinical-care/considerations-special-groups.html
53. Centers for Disease Control and Prevention. (2024, September 10). COVID-19 vaccination for women who are pregnant or breastfeeding. https://www.cdc.gov/covid/vaccines/pregnant-or-bre-
astfeeding.html
54. Terrault, N. A., Lok, A. S. F., McMahon, B. J.,et al. (2018). Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology, 67(4),
1560–1599
55. Asafo-Agyei KO, Samant H. Pregnancy and Viral Hepatitis. [Updated 2025 Jan 22]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.
ncbi.nlm.nih.gov/books/NBK556026/
56. U.S. Department of Health and Human Services. (2025, June 12). Recommendations for the use of antiretroviral drugs during pregnancy and interventions to reduce perinatal HIV transmission
in the United States. In ClinicalInfo.HIV.gov. https://www.ncbi.nlm.nih.gov/books/NBK586310
57. Carvajal, A., & Vigil-De Gracia, P. (2022). Monkeypox and pregnancy. American journal of obstetrics & gynecology MFM, 4(6), 100746. https://doi.org/10.1016/j.ajogmf.2022.100746
58. Andrieu, J., Mège, J. L., & Mezouar, S. (2025). Monkeypox Virus and Pregnancy. Journal of medical virology, 97(4), e70337. https://doi.org/10.1002/jmv.70337